(4-Amino-piperidin-1-yl)-phenyl-methanonehydrochloride, 95.0%, 500mg

N-(2-methoxyethyl)-2-piperazin-1-ylacetamide, 1g

(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide, 98%, 50mg

1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid, 95.0%, 5g

(5-Ethoxy-2-fluorophenyl)boronic acid, 95.0%, 25g

6-Cyclopropyl-1,3-dimethyl-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acid, 95.0%, 1g

4-((4-Bromo-2-fluorophenyl)amino)-6-methoxyquinazolin-7-ol, 95.0%, 5g

7-CHLORO-6-NITRO-1,2,3,4-TETRAHYDROISOQUINOLINE, 95%, 1g

N-(2-BROMOPHENYL)-N-METHYL-METHANESULFONAMIDE, 98.0%, 1g

Placas TLC POLYGRAM® SIL G, 4 x 8 cm, 50 Unidad(es)

H-Cys(Trt)-OtBu.HCl, 95.0%, 25g

5-Amino-1-methyl-1H-pyrazole-4-carboxylic acid, 95.0%, 25g

N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide, 100mg